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Telomeres and Telomerase 
Activity in the Human Placenta
Marie Jirkovská, Marie Korabečná and Soňa Laššáková
Abstract
Placenta is a transient organ ensuring the intrauterine development of the indi-
vidual. To meet fetal requirements, rapid and continuous cell proliferation enlarges 
the areas of tissues maintaining maternofetal transport. The cell division in placenta 
is accompanied with shortening of telomeres leading to cell senescence. Telomerase 
activity, on the other hand, ensures replication of telomeres and allows the organ to 
serve till the end of pregnancy. This balanced process may be negatively influenced 
by unfavorable circumstances. Here, we summarize available data on telomere 
length as well as telomerase activity in placentas from normal and complicated 
pregnancies; attention is also paid to the comparison of methods used in relevant 
studies.
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1. Introduction
The core of cell proliferation is the division of cells and replication of chromo-
somes. Among other factors, it is also regulated by the length of telomeres since 
short telomeres will either recruit telomerase, or, in the absence of telomerase, 
induce senescence, apoptosis, or genome instability, or activate a DNA damage 
response (e.g., telomere recombination). The main function of telomeres is the 
protection of chromosomal integrity during DNA replication; moreover, they them-
selves are protected by a shelterin protein complex. Telomeres stabilize the ends of 
linear chromosomes and prevent the ends from being recognized as a double strand 
break. In human cells, telomeres contain hexameric tandem repeats, 5′TTAGGG 
3′, of DNA sequence. To maintain the proliferative ability of cells, the elongation 
of telomeres is executed by adding telomeric DNA repeats to the 3′chromosomal 
ends by telomerase. In the absence of telomerase, the telomeres shorten in every cell 
division. Telomerase as an RNA-dependent DNA polymerase repairs the sequences 
of telomeres after each cell division; but in humans, this enzyme is active in stem 
cells, germ cells [1–3], and cancer cells only.
During development of an individual, mature oocytes and cleavage stage 
embryos display low or absent telomerase activity, whereas in the blastocyst stage, 
its activity is high again. As in cells during early cleavage, the telomeres become 
remarkably longer, and an alternate lengthening of telomeres may play a role in 
their elongation. Processes of telomeric DNA recombination between homologous 
sister chromatids take place in the cleavage stage, and the length of telomeres is 
then maintained from the blastocyst stage onward by telomerase [4]. Telomeric 
DNA recombination between telomeres on separate chromosomes such as gene 
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conversion and the elongation of telomeres by DNA polymerase activity by mecha-
nisms like break-induced replication can lengthen telomeres independently of 
telomerase activity [5].
The mechanism of DNA replication results in progressive shortening of the 
ends of linear DNA molecule. That shortening limits the life span of individual cells 
and it is referred to as replication senescence [6]. Recently, it is well known that 
telomere attrition is observed during normal cellular aging, but telomere dysfunc-
tion may also contribute to the onset and progression of age-related diseases like 
atherosclerosis and myocardial infarction [7]. Telomere attrition is regarded as one 
of the so-called hallmarks of aging as proposed in [8].
Many tissues and organs contain cycling undifferentiated stem cells that provide 
cells for their renewal. The frequency of their mitotic division is different among 
tissues; examples of the most active are epidermal cells and cells of the bone 
marrow. Those cells are characterized by high levels of telomerase expression and 
disorders of telomere homeostasis cause, or at least take part in, the pathogenesis of 
serious inherited diseases, for example, dyskeratosis congenita [9], aplastic anemia, 
other bone marrow syndromes [10–12] and/or idiopathic pulmonary fibrosis [13]. 
Moreover, increased incidence of diabetes mellitus was identified in patients suffer-
ing from those pathologies [14]. Inherited bone marrow failure syndromes threaten 
also the prenatal development due to fetal malformations and intrauterine growth 
retardation accompanied with an abnormally small placenta [15].
The correct function of telomerase-telomere complex depends on both genetic 
predispositions and external factors (age, reactive oxygen species, and exogenous 
genotoxic factors). Mutations in the telomerase holoenzyme in either of the two 
genes, TERT encoding the reverse transcriptase, or TERC encoding the RNA tem-
plate for the synthesis of telomeres by telomerase, can cause remarkable telomere 
attrition even in hemizygous individuals [16] and may take part in hereditary 
conditioned telomere disorders [17–20].
2. Placenta in pregnancy
The prenatal development of an individual is conditioned by placenta, the 
transient organ that functions exclusively for the time of pregnancy. In order to 
meet fetal requirements, the placenta holds the functions of still undeveloped fetal 
organs, for example, lung and kidney. It is the site of transport of oxygen, ions, 
nutrients, and maternal immunoglobulins from mother to fetus, and carbon dioxide 
and wastes from fetus to mother. The placenta also maintains pregnancy by produc-
tion of steroid and protein hormones and other factors. Due to its position between 
maternal and fetal bloodstreams, the placenta acts as a barrier against infectious 
agents and regulates the maternal immune tolerance, gas exchange, and fetal 
nutrition. On the other hand, its structure and function are negatively impacted by 
maternal and fetal metabolic disturbances in pathological pregnancies.
Placental tissues originate in extraembryonic structures, that is in trophoblast, 
the outer layer of the blastocyst, which invades maternal tissues and gives rise to the 
cytotrophoblast and syncytiotrophoblast, and in extraembryonic mesoderm that is 
requisite for the formation of placental vasculature and supporting connective tissue.
The progress of fetal growth and maturation of fetal organs is essentially accom-
panied by the growth of placental size. It is performed by continuous cell prolifera-
tion till the term of gestation [21] and balanced with differentiation and apoptosis 
in all tissue compartments. The weight of term placenta is 500–600 g, the estimated 
surface area of syncytiotrophoblast available for maternofetal transport is 11–13 m2, 
and the inner fetal capillary surface area is about 12 m2 [22].
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Human placenta is formed by chorionic plate and its repeatedly branched 
projections, chorionic villi, that are immersed in maternal blood circulating in the 
intervillous space. The growth of villi goes hand in hand with fetal growth. They 
develop into various types during pregnancy, and their classification depends on 
size and structural features. Basically, each villus is covered by the layer of tropho-
blast consisting of continuous cytoplasmic mass with numerous nuclei, that is, 
syncytiotrophoblast, and cuboidal cells of cytotrophoblast appearing as a continu-
ous layer underneath syncytiotrophoblast in early gestation, but sparsely spread 
in term placenta. As nuclei in syncytiotrophoblast do not divide, cytotrophoblast 
cells play the role of stem cells of trophoblast. They undergo mitotic division, and 
their fusion with syncytiotrophoblast enlarges its mass. As shown by detection of 
cell cycle markers (e.g., Ki67, PCNA), they display proliferative potential over the 
duration of pregnancy [23–25].
The other source of placental tissues is extraembryonic mesoderm. For the 
placental development, this cell population gives rise to the mesenchyme adjoining 
villous trophoblast. Mesenchymal derivatives, that is, cells of connective tissue, 
endothelial cells, pericytes, and smooth muscle cells then form villous stroma and 
vascular bed. It is obvious that they follow the growth of trophoblast, and their 
proliferation and subsequent differentiation contribute to the formation of new 
functionally efficient villi, and thus to the enlargement of the organ and its func-
tional capacity. It is significant particularly in the third trimester when the rapid 
development of terminal villi accompanies the rapid enlargement of fetal size [22]. 
Previous studies have demonstrated the proliferative potential of cells in villous 
vascular bed and stroma in early pregnancy as well as at term [24, 25]. The pro-
liferative potential of cells in terminal villi of normal human term placenta is also 
demonstrated in Figure 1.
In order to provide nutrition for the increasing metabolic requirements of 
growing fetus, the placenta displays continuous cell proliferation during its entire 
existence. Despite the fact that fetal demands attain their maximal level at term, it 
is expected that cells in placenta at term decrease their proliferative capacity due 
to telomere shortening and undergo senescence similar to somatic cells in other 
organs. It is also supposed that those changes in telomere length might take part in 
the initiation of parturition [26]. Telomere shortening during pregnancy was found 
also in the placenta of mice [27]. As shown in another study in mouse, the propor-
tion of representative short telomeres, that is, 3- and 5-kb telomere fragments, 
Figure 1. 
Proliferative activity of cytotrophoblast (arrows), stromal cell (arrowhead), and capillary endothelium 
(asterisk) in terminal villi of normal term placenta demonstrated by Ki-67 immunohistochemistry. 
Bar = 50 μm.
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significantly increases toward the end of pregnancy. The authors conclude that the 
quantity of representative short telomeres increases prior to parturition and takes 
part in the mediation of cellular aging in the placenta, finally leading to parturition 
[26]. Those findings are consistent with other studies regarding the impact of short 
telomere rather than average telomere length [28].
Due to its location in maternal uterus, the placenta is influenced by any abnor-
mal metabolic conditions in both mother and fetus. The negative influence demon-
strates itself in pathological structural features as well as in impaired function. In 
such organ displaying mitotic activity, altered telomere homeostasis may take part 
in those adverse changes. Here, we summarize data on telomere length and telomer-
ase activity in placentas from normal pregnancies and pregnancies complicated by 
metabolic disturbances threatening pregnancy outcome, as are maternal diabetes 
mellitus, preeclampsia, and intrauterine growth restriction.
3. Analysis of telomere homeostasis—methodological approaches
In view of the facts mentioned above, telomere length emerged as a promising 
marker generally in medicine, but the utility of such measurements highly depends 
on valid methodologies [7]. The average telomere length is highly variable among 
different cell types and among different individuals. There are also gender differ-
ences, which could be detected at birth. Additionally, the average telomere length 
declines with age [16].
Telomeres may be repaired either by the enzyme telomerase using its RNA 
template or by recombination. The methodologies examining telomere homeo-
stasis in different tissues are therefore based not only on the determination 
of the length of telomeric DNA sequences, but they examine also the status 
and expression of the reverse transcriptase (hTERT) and the RNA template 
(hTERC) genes and recombination events on selected telomeres. In the follow-
ing paragraphs and in Table 1, we summarize the main features and limitations 
of methodologies employed in placenta research, alternatively the methods 
applicable on human samples.
3.1 Methods examining telomeric DNA sequences
Terminal restriction fragment (TRF) analysis was originally developed to deter-
mine the lengths of telomeres in 1988 by Moyzis et al. [54]. Genomic DNA is isolated 
and then digested with a mixture of restriction enzymes that are selected to avoid the 
cutting of telomeric and subtelomeric sequences. The DNA fragments obtained after 
such a digestion are separated in agarose gel and hybridized with the probe contain-
ing telomeric sequences [55]. The need for high amounts of highly integral DNA 
samples represents one of the main limitations of this methodology [7].
Polymerase chain reaction (PCR)-based methodologies were elaborated to overcome 
limits of the previous method. Cawthon [56] reported the technique based on quan-
titative PCR (qPCR). The sequences of primer pairs proposed by Cawthon avoid 
the primer dimer formation which frequently occurs when repetitive sequences are 
amplified. Cawthon’s qPCR technique and its subsequent modifications [56–58] 
belong to the most frequently used methods. Telomere length is quantified rela-
tively—the ratio T/S between the quantity of repetitive telomeric sequences (T) and 
the quantity of sequences representing a single copy gene (S) is calculated. These 
ratios correlated very well with the absolute telomere lengths measured by TRF 
method in Cawthon’s original study [56]. An attempt to standardize this methodol-
ogy over large spectrum of laboratories was made [59].
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O’Callaghan and Fenech [60] described the modification of qPCR-based technique 
allowing the determination of an absolute telomere length due to the use of artificially 
synthesized DNA standard containing the defined number of telomeric repeats.
PCR-based techniques are quite popular among researchers because they require 
lower DNA quantity and usual laboratory equipment. Due to their relatively low 
costs, they may be employed in high-throughput epidemiologic studies. One short-
coming of PCR-based methodologies is that the resulting values inform only about 
the average telomere length in the specimens.
Single telomere length analysis (STELA) targets telomeric DNA from a single 
chromosome using primers specific to subtelomeric sequences [61]. All individual 
chromosomal subtelomeric regions do not contain suitable specific sequences; 
therefore, the method is able to examine only a limited set of chromosomes [7]. 
Using this methodological approach, Garcia-Martin et al. [32] found considerable 
intra-sample variability in examined placentas.
Quantitative fluorescence in situ hybridization (Q-FISH)-based techniques are 
focused more on the work with cells than with isolated DNA. A fluorescent probe, 
mostly peptide nucleic acid (PNA) probe, complementary to telomeric repetitive 
sequences is hybridized to denatured DNA of metaphase chromosomes or inter-
phase nuclei. The cells may be fresh, frozen, or formaldehyde-fixed and paraffin-
embedded. The application of metaphase Q-FISH, which was developed in 1996 
by Lansdorp and colleagues [62], results in the estimation of the length of all 92 
telomeres in human cells. It allows the detection of telomere free ends. The most 
serious limitation of this approach is the requirement of metaphases from mitoti-
cally active cells. The method is labor intensive [7, 62].
Method References
Telomere length analysis based on isolated DNA
 TRF [29–31]
 STELA [32–34]
 Q-PCR, T/S ratio [29, 35–38]
Telomere length analysis based on examination of interphase nuclei
 Interphase Q-FISH [36, 39–45]
Determination of gene copy numbers in situ
 hTERT-FISH [36]
 hTERC-FISH [36, 39, 41, 46]
hTERT expression
 Immunohistochemistry [43, 45, 47]
 RT-PCR for hTERT [29, 41, 48–51]
hTERC expression
 RT-PCR for hTERC [29]
Telomerase activity determination
 TRAP [33, 38, 48, 52, 53]
 TRAP in situ [52, 53]
Genome-wide technologies
 Illumina methylation array [37]
Table 1. 
Experimental methods used in placenta research.
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Interphase Q-FISH, first described in 1998 by de Pauw and colleagues [63], is 
applicable on nondividing cells. It compares the fluorescent signals obtained after 
hybridization with a telomere-specific probe and with a probe targeting a single 
copy gene. Its results inform, similar to the results of qPCR methodologies, about 
the average length of the telomeres in examined cell, the method is not able to 
recognize each individual telomere as metaphase Q-FISH.
A method for telomere capture evaluation based on interphase Q-FISH has been 
established by Amiel et al. [64]. When telomeres shorten to the critical length, 
repair pathways are activated. In the process of telomere capture, a critically short 
telomere obtains a new telomeric sequence from another chromosomal end. In the 
original method, the number of fluorescent signals for a single copy gene, SNRP, 
which is localized on chromosome 13, was compared with the number of signals for 
15qter region of this chromosome [64] to follow not only random aneuploidy but 
also telomere capture or translocation of telomere. The methodology was also used 
in placenta research [39, 48].
The pq-ratio assay described in 2001 by Perrem et al. [40] belongs to methods 
that directly examine telomere recombination. This assay measures the variation in 
telomere lengths at the p and q arms of a chromosome. The telomere ratio for most 
chromosomes is expected to be q/p~1, because the telomeres at both ends of a given 
chromosome shorten at a similar rate. If recombination is used to maintain the 
ends, then it could alter the length of at least one telomere by a random amount of 
telomeric repeats. This results in variable values for the pq-ratio. The pq-ratio assay 
is very sensitive, and the data may become biased as the telomeres shorten. Small 
changes on a short telomere may be overrepresented and telomeres with no signal 
will not be represented at all [40, 65, 66].
Chromosome orientation-FISH (CO-FISH) was first described in 1993 [67, 68] 
as a method for strand-specific FISH. The method is dependent on cultivation of 
analyzed cells because it requires incorporation of bromodeoxyuridine (BrdU) 
into newly synthesized strands. This step allows subsequent enzymatic removal of 
BrdU containing strands after their damage caused by UV light in the presence of 
the dye Hoechst 33258. The remaining strands then serve as single-stranded targets 
for FISH. This approach allows differentiation between the telomeres produced 
via leading- or via lagging-strand DNA synthesis, and it enables the study of sister 
chromatid exchanges (SCE) and inversions in telomeric regions [69, 70].
The methodology of directional genomic hybridization (dGH) represents the 
cytogenomic extension of strand-specific hybridization. Telo-dGH recognizes 
terminal exchange events—terminal inversions and generally different forms of 
genetic recombination occurring near the telomeres, namely sister chromatid 
exchange (SCE) [71].
Flow-FISH represents the modification of interphase Q-FISH, which was intro-
duced in 1998 by Hultdin et al. [72]. The cells in suspension are hybridized with 
fluorescent probes and then examined using flow cytometry. This approach is tech-
nically very demanding because the unfixed cells are often fragile and clustering. 
The technique is very sensitive to preservation of cells. FISH probes may also have 
affinity to cytoplasmic structures [7]. Higher numbers of cells are needed (typically 
> 1 × 105), the assay determines mean telomere lengths and it does not account for 
aneuploidy or SFE (signal free ends) but the methodology was successfully used in 
numerous studies [73–75].
TELI-FISH is a combined FISH/immunofluorescence method which was 
developed in 2002 to assess human telomere lengths from standard formalin-fixed 
paraffin-embedded tissues. Combination with immunostaining allows the simulta-
neous identification of specific cell types. The assay requires very few cells (10–15). 
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Validation showed excellent agreement with the commonly used TRF method based 
on Southern blotting [76].
Microdissection followed by qPCR allows selection of cells for analysis using 
classical histological technique and it is suitable for the studies based on archival 
material [35]. Microdissected cells may be examined by qPCR methodology, and 
therefore, its main disadvantage is that it provides information only about the 
relative average length of telomeres in analyzed samples. The methodology does not 
result in the determination of the lengths of the longest or the shortest telomeres 
contained in the sample. Comparison of T/S ratios related to a reference sample 
allows evaluation of differences between the groups of samples (for instance 
between healthy controls and patients).
Whole genome sequencing (WGS) captures sequence information from the 
entire genome, including the telomeres, and is increasingly being applied in 
research and in the clinic. In 2014, Ding et al. [77] demonstrated a novel method, 
TelSeq, which allows measurement of average telomere length by using whole 
genome or exome sequencing data. It was the first study that evaluated in detail 
the relationship between the frequency of telomere repeats and telomere length. 
With the potential to be a relatively high-throughput method, this may overtake 
qPCR as the method of choice in future studies. Their study was the first com-
putational method that had been validated against an established experimental 
method (Southern blot measurements of the mean length of terminal restriction 
fragments).
3.2  Methods examining genes coding for telomerase and its RNA components, 
their expression, and telomerase activity
The telomere length is closely associated with telomerase (human telomerase 
reverse transcriptase—hTERT) activity (TA) and the availability of its RNA compo-
nent (hTERC or TERRA—telomeric repeat-containing RNA) in tissues.
The copy number of both genes hTERT and hTERC in nuclei in archive tissues or 
cultivated cells is examined by FISH methodology. This approach was applied also 
in placenta research [36, 41, 46, 48]. RNA-FISH is based on the use of fluorescently 
labeled probes and allows the cellular localization of TERC [78].
The presence of telomerase itself may be detected in tissues by means 
of immunohistochemistry—a methodology which is generally well established in 
laboratories of pathologists [76]. This methodology was also widely used in placenta 
research—see reference in Table 1.
In Table 1, the studies that examined the expression of hTERT using reverse 
transcription and subsequent qPCR to quantify the amount of hTERT transcripts are 
also summarized.
The telomerase activity may be measured by a wide panel of methodologies 
based on addition of telomerase substrate and detection of amplified telomerase 
products by telomere repeat amplification protocols—TRAPs—developed by Kim 
et al. [79]. Recently existing numerous methodological modifications of this 
approach were reviewed by Mensa et al. [78].
hTERC (TERRA) is a long noncoding RNA, which can be transcribed from 
nearly all telomeres in mammalian cells because its transcription starts from their 
subtelomeric regions. Therefore, the quantity of such transcripts can be measured 
by RT-qPCR starting from RNA isolated from analyzed cells or tissues followed 
by reverse transcription and PCR with chromosome-specific primers. Molecular 
mechanisms associated with the role of TERC in telomere reparation are intensively 
studied [80, 81].
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Northern blotting or RNA dot blotting needs mostly radiolabeled probes and can-
not detect the minor changes in quantity of TERC [78].
Detection of G4 quadruplexes using antibodies is based on the fact that during 
hTERC transcription, the RNA:DNA hybrids at the chromosome ends are formed, 
and they can fold into G-quadruplexes [78]. The G-quadruplex structure formed 
by telomere DNA plays also an important role in the regulation of the telomerase 
reaction [82].
3.3 Methods examining epigenetic changes and chromatin structure
Not only the presence of DNA sequences of genes hTERT and hTERC but also 
their functional state determined epigenetically plays a crucial role in the regulation 
of their expression.
Wilson et al. [37] used array technology (Illumina Infinium Human Methylation 
450 BeadChip) to study methylation alterations in genes hTERT, DNMT1, and 
DNMT3A in human placentas. MALDI-TOF technology was employed to determine 
the level of DNA methylation of hTERC in placenta using Sequenom EpiTyper 
platform [29]. Lower levels of gene methylation were found in normal placentas 
compared with other somatic cells.
Quantitative Telomeric Chromatin Isolation Protocol (QTIP) was introduced 
in 2013 by Grolimund et al. [83]. It allows the comprehensive determination of 
telomere protein composition and the quantitative comparison of telomere protein 
compositions between cells with different telomeric states. Chromatin is cross-
linked, immunopurified, and analyzed by mass spectrometry. The methodology may 
be also adapted for examination of other chromatin regions within the genome [83].
4. Placenta in normal pregnancy
The assessment of telomere length in normal pregnancy gives important data 
regarding dynamics of placental cellular proliferation. The study on third trimester 
placentas using the qPCR has shown decreased telomere length between gestational 
weeks 28 and 42 (13.98–10.56 kbp) [38]. The application of qPCR and Southern 
blot-based terminal restriction fragment (TRF) assay confirmed considerably 
longer telomeres in first trimester villi than in term placentas, telomeres of which 
were found to be longer than those in cord blood mononuclear cells [29, 84].
Some authors took into consideration that the position of villous tissue in the 
placenta may influence the telomere length, and therefore collected and processed 
samples of the whole placenta from more locations [29, 37, 84]; nevertheless, no 
site-specific differences of telomere length were determined except [84] showing 
that the telomerase activity was detected in term placenta restricted to biopsy sites 
near umbilical cord only. Moreover, the Southern blot-based TRF assay discovered 
longer telomere length in placental samples than in cord blood cells [84]. The study 
by qPCR proved that telomeres in placentas of female fetuses are longer than in 
placentas of male fetuses at the same gestational week. This finding suggests an 
influence of hormonal milieu during intrauterine development [37]. On the other 
hand, the other study performed by single telomere length analysis (STELA) 
revealed neither influence of fetal sex nor influence of the mode of delivery [32].
The above-mentioned findings in chorionic villi and normal placenta suggest that 
telomere length is maintained by active telomerase during pregnancy. Nevertheless, the 
papers dealing with this topic present equivocal results. Using TRAP assay, Wright et al. 
[33] found no detectable telomerase activity in placenta. To the contrary, telomerase 
activity studied by TRAP assay and in situ TRAP assay was found in both chorionic 
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villi at 5–14 weeks of gestation and normal placentas at 23–42 weeks of gestation 
[49]. Expression of telomerase protein was detected by immunohistochemistry in 
cytotrophoblast of chorionic villi [47, 85]. Decreasing relative telomerase activity was 
shown in comparison of chorionic villi in first, second and third trimester. In normal 
villi from 6 to 40 gestational weeks, the presence of telomere RNA component (TERC) 
was demonstrated, whereas telomerase reverse transcriptase (TERT) was not found 
in samples from second and third trimesters [86]. Immunohistochemical reaction 
revealed telomerase expression in trophoblast and stroma of villi in 10th week, but not 
in term placenta [87]. Using RT-PCR method, the hTERT-RNA expression was found in 
normal chorionic villi from 6th to 10th gestational week as well as in normal placentas 
from 12th to 41st gestational week, whereas hTERT protein expression was found in 
chorionic villi, but only in the fourth part of placental samples [88].
5. Placenta in pregnancy pathologies
It is evident that normal placental growth and development carried out by cell 
proliferation is conditioned by appropriate telomere length ensured by homeostasis 
of telomerase system. For optimal course of those processes, normal metabolic 
milieu is necessary in mother, placenta, and fetus. The most critical condition of 
intrauterine development is adequate oxygen supply. The early pregnancy phase, 
that is, first 10 weeks, runs under low oxygen levels. This relative hypoxia before 
the constitution of the fetoplacental and uteroplacental blood circulation induces 
various factors, one being the hypoxia-inducible factor 1, that upregulates hTERT 
expression (and telomerase activity), and its decrease with gestational age is in 
correlation with decrease of telomerase activity logically followed by telomere 
shortening [88]. As the placenta consumes about 40% of the oxygen supplied to 
fetoplacental unit [89], the hypoxic conditions have negative impact on all processes 
running there. And hypoxia also represents a key factor in genesis of pregnancy 
pathologies discussed in the following parts of this chapter.
5.1 Maternal diabetes mellitus
There are two main forms of maternal diabetes mellitus, the insulin-dependent 
form with onset before conception, and gestational diabetes diagnosed usually in 
second half of pregnancy that disappears after birth. In the insulin-dependent type 
diabetes, an autoimmune process destroys β-cells of the islets of Langerhans com-
pletely and the patient is then treated by insulin supplementation.
As shown in experiments with mice, the type 2 diabetes, and similarly gesta-
tional diabetes, may involve telomere shortening during pathogenesis. Shorter 
telomeres are associated with impaired β-cell regeneration, impaired glucose-stim-
ulated insulin secretion by disorders of insulin release leading to impaired glucose 
tolerance as well as to increased β-cell senescence [14, 90].
Both forms of maternal diabetes are characterized by maternal hyperglycemia 
and thus higher amount of glucose transported to fetus. Metabolic complications 
derived from hyperglycemia threaten the mother; manifest themselves in placental 
structure and function; have negative influence on fetal well-being, perinatal 
morbidity and mortality; and long-lasting effect on the postnatal life of the indi-
vidual. In pregnancies complicated by maternal diabetes mellitus, the alterations of 
placental structure and function as well as the pregnancy outcome depend on the 
quality of metabolic control. Placentas from poorly controlled diabetes are larger 
and heavier and microscopic picture shows disturbances of villous maturation 
[22]. The oxidative stress produced by imbalance of glucose and oxygen supply 
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in fetoplacental unit is compensated by enhanced placental angiogenesis dem-
onstrated by higher villous capillary branching [91]. It is possible to suppose that 
both, the higher placental weight and enhanced angiogenesis, are a consequence of 
escalated cell proliferation leading to exhaustion of telomeres available for mitotic 
division.
Regarding the telomere length in placenta from pregnancies complicated by 
maternal diabetes, the available data are not quite consistent. In the qPCR-based 
study examining large cohort of placentas, maternal diabetes was found associated 
with longer telomere length [38]. In another study comparing telomere length in 
cytotrophoblast of placentas from poorly controlled maternal diabetes and normal 
pregnancies by FISH method, the result indicated shorter telomeres in the diabetic 
group [42]. In the same groups of patients, the immunohistochemically identified 
telomerase expression, the expression of mRNA for hTERT, and the expression of 
TERC gene copy number were lower in diabetic placentas [41]. On the other hand, 
no difference of mean telomere length was found in peripheral villi of normal 
placentas and placentas in well-controlled maternal diabetes examined by laser 
capture microdissection and qPCR [35], although the study on the same placental 
material discovered lower proliferative potential of cytotrophoblast and vascular 
endothelium of terminal villi in maternal diabetes [25]. Single telomere length 
analysis (STELA) was used for measurement of telomere length in normal placentas 
and placentas from gestational diabetes treated either by lifestyle intervention or by 
metformin or insulin therapy. The result showed that the therapy by metformin or 
insulin protected from telomere shortening in placentas of male fetuses [34].
5.2 Preeclampsia
Preeclampsia is a disease of pregnancy characterized by new-onset maternal 
hypertension and proteinuria. It may begin in 28–34 gestational weeks (early-onset 
preeclampsia) or after 34 weeks (late-onset preeclampsia). It is commonly accepted 
that the preeclampsia originates in deficient placentation, that is, decreased inva-
sion of the maternal tissues by extravillous trophoblast. Under normal conditions, 
the endothelium and smooth muscle cells of uterine spiral arterioles are replaced 
with trophoblast and their diameter becomes wide allowing delivery of blood at low 
pressure to the intervillous space. The decreased trophoblastic invasion produces 
narrow uteroplacental arteries and the resulting malperfusion of the intervillous 
space causes oxidative stress of the fetoplacental unit manifested among others by 
reduced development of the villous tree and placental growth retardation. Increased 
placental proliferative activity found using detection of PCNA and Ki67 in pre-
eclampsia may be a sign of increased cell turnover [92]. The associated systemic 
vascular inflammation in maternal organism may cause injury of multiple organs.
In placentas in preeclampsia, the analysis of villous cytotrophoblast based on 
the quantitative FISH method showed shorter telomeres, more end-to-end telomere 
aggregates, and abnormal TERC gene copy number as well as decreased hTERT 
expression detected by immunohistochemistry [39, 43, 44]. Common expression 
of hTERT protein and HIF-1α in term preeclamptic placenta gives an evidence of 
response to hypoxia by telomerase upregulation [88]. Nevertheless, the measure-
ment of average telomere length by qPCR did not show significant differences 
between control, early-onset preeclamptic, and later-onset preeclamptic placentas 
[37]. Another study has also shown no differences of telomere length between 
normal placentas and placentas in preeclampsia [30]. Enhanced levels of placental 
hTERT-mRNA in preeclampsia [50] if not associated with longer telomeres as a 
result of enhanced telomerase activity suggests that there is a conceivable distur-
bance in translation or post-translation processes of the enzyme protein.
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6. Intrauterine growth restriction
In intrauterine growth restriction (IUGR), the growth and development of fetus 
is delayed by 3–4 weeks regarding the gestational age and the birth weight is low, 
under 10th percentile for gestational age. Fetal growth restriction is associated with 
restricted placental size caused by arrest mechanisms reducing cell proliferation 
[45]. There are two types of IUGR, symmetric and asymmetric. The fetus display-
ing symmetric IUGR has normal body proportion, the fat and muscle tissue are 
reduced. It is usually associated with genetic factors causing, for example, already 
mentioned bone marrow syndromes [9–12] or infections. The asymmetric IUGR 
is characterized by normal size of head and reduced chest and abdominal circum-
ference due to reduced fat and muscle tissue. It is often associated with placental 
insufficiency arising, for example, in preeclampsia and may be related to oxidative 
stress.
Studies performed by quantitative FISH method and RT-PCR on placental 
cytotrophoblast in IUGR gave an evidence of shorter telomeres, lower telomerase 
activity, decreased hTERT mRNA, and decreased TERC gene copy number  
[45, 46, 48]. The relative telomere length and hTERT expression were found lower 
in cytotrophoblast of placentas in IUGR as well as in IUGR combined with pre-
eclampsia [43].
Lower proliferative potential found in placenta in IUGR [52, 70, 76, 93] seems 
to be consistent with decreased telomerase activity in cytotrophoblast of IUGR 
placenta [52, 76]. In placenta associated with asymmetric IUGR, only weak, if any, 
telomerase activity, hTERT expression, and copy numbers of telomerase reverse 
transcriptase were found by qPCR and in situ TRAP assay [49, 51, 53]. Shorter telo-
meres associated with higher expression of cell senescence markers were found in 
placenta samples in IUGR [31] and shorter telomeres detected by quantitative FISH 
technique and reduced average telomere length detected by qPCR were shown in 
[36]. To the contrary, no difference was revealed in average telomere length assessed 
by qPCR between normal placenta and placenta in IUGR [37].
7. Conclusions
Appropriate fetal growth and development is conditioned by appropriate 
placental growth and development. It is accomplished by balanced cell prolifera-
tion, differentiation, and apoptosis. Cell proliferation is influenced by the length of 
telomeric sequences of chromosomes and their elongation due to telomerase activ-
ity. This review article summarizes available data on telomere length and telomerase 
activity of placenta in pregnancy-complicating situations, that is, maternal diabetes 
mellitus, preeclampsia, and intrauterine growth restriction (Table 2) as well as 
methods used for this research (Table 1).
In normal placentas, longer telomeres and higher telomerase activity were found 
in early pregnancy, they gradually decreased till the term. Although the available 
studies on placentas from pregnancies complicated by maternal diabetes are not 
numerous, their results corroborated by experimental studies suggest that diabetic 
metabolic conditions contribute to telomere shortening and that the appropriate 
metabolic control achieved by adequate treatment may function as a prevention 
of this adverse process. The results of research on telomere length and telomerase 
activity in preeclampsia are still equivocal and rather suggest debatable comparabil-
ity of methods applied in those studies. The telomere length in placenta associated 
with IUGR was found lower and accompanied with decreased expression and 
activity of components of telomerase apparatus.
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Maternal diabetes mellitus, preeclampsia as well as IUGR do not only complicate 
pregnancy but are also taken as causes of adverse outcomes for individuals later in 
postnatal period. Further investigation of the effect of factors influencing telomere 
length and telomerase activity may contribute to better understanding of those links. 
The placental DNA is identical to the DNA of fetal cells and the period of its existence 
equal to the prenatal period of the fetus spent in the same maternal environment. As 
telomeres are susceptible to external conditions of maternal milieu (i.e., oxidative 
stress, reactive oxygen species, exogenous genotoxic insults), those epigenetic influ-
ences may accelerate their shortening [94]. Prospective studies in experimental models 
and of course in long-time prospective studies in human should elucidate if there is a 
relation of final telomere length in placentas at term and newborn and if the measure-
ment of placental telomere length could have a predictive potential for individual.
Recently, the immunomodulatory role of telomeric sequences was recognized 
[78, 95]. Telomeric sequences originated from trophoblasts may circulate in the pool 
of cell-free DNA in maternal plasma and contribute to timing of parturition [26] by 
stimulation of maternal immune response against placenta. The role of telomeric 
sequences contained in cell-free DNA in plasma of healthy persons in the regulation 
of immune system performance was also described [95]. Additionally, the telomeric 
sequences were found also in cytoplasm where they regulate inflammatory response 
via their interaction with TLR9 receptor [78].
In view of all these facts, the study of telomeres and their homeostasis in 
placenta seems to be crucial for the understanding of pathogenesis in the broad 
spectrum of pregnancy complications.
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Diagnosis Telomere length Telomerase activity
Normal placenta Telomere length is reduced in the course of 
pregnancy; placental telomere length is not 
site-specific [32, 33, 37, 38, 84]
hTERT expression and 
telomerase activity were found 
[47, 49, 84, 85]; telomerase 
activity decreases in the course 
of pregnancy [86–88]
Placenta associated 
with maternal 
diabetes mellitus
Maternal diabetes is associated with longer 
placental telomeres [38]; there is no difference 
in placental telomere length in well-controlled 
diabetes [34, 35]; telomeres are shorter in 
placentas from poorly controlled diabetes [42]
Lower expression of hTERT, 
hTERT-mRNA, lower TERC 
copy number in placentas from 
poorly controlled diabetes [41]
Placenta associated 
with preeclampsia
No differences of telomere length between 
normal placentas and placentas in 
preeclampsia [37, 84]; shorter telomeres, 
more end-to-end telomere aggregates, higher 
telomere aggregates count [43, 44]
Lower expression of hTERT 
[44], abnormal TERC copy 
gene number [39]; higher 
expression of hTERT mRNA 
[50]
Placenta associated 
with IUGR
Shorter telomeres [31, 36, 45]; no difference in 
telomere length [37]
Lower expression of hTERT, 
hTERT-mRNA, lower TERC 
copy number [46, 48, 51–53]
Table 2. 
Summarized data on telomere length and telomerase activity in normal placenta and placenta in case of 
maternal diabetes mellitus, preeclampsia, and IUGR.
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